Millennium Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC
1:17-cv-00422
Overview
Parties
Defendant
Amneal Pharmaceuticals LLC Operating Company
Represented By
2 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Plaintiff
Millennium Pharmaceuticals, Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Millennium Pharmaceuticals, Inc. v. Zydus Pharmaceuticals (USA) Inc.
Millennium Pharmaceuticals Inc. v. Actavis LLC
Millennium Pharmaceuticals Inc. v. Hospira, Inc.
Millennium Pharmaceuticals Inc. v. Sun Pharmaceutical Industries Limited
Millennium Pharmaceuticals Inc. v. Mylan Laboratories Limited
Millennium Pharmaceuticals Inc. v. Hetero Labs Limited
Millennium Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc.
Millennium Pharmaceuticals Inc. v. Fresenius Kabi USA LLC
Millennium Pharmaceuticals Inc. v. Actavis Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6713446
Formulation of boronic acid compounds
|
Filed: 2002-01-25
Issued: 2004-03-30
|
Expired (Term Ended)
Expires: 2022-01-25
|
|
|
US6958319
Formulation of boronic acid compounds
|
Filed: 2003-09-18
Issued: 2005-10-25
|
Expired (Term Ended)
Expires: 2022-04-14
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
6
Dispositive
0
Granted
0
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings